ARK Genomic Revolution ETF (ARKG) is a publicly traded company in the Financial Services sector, operating within the Asset Management industry.
ARKG has IPO date of 2014-10-31, listed on the Chicago Board Option, a market capitalization of $1.18B.
ARKG is an actively managed Exchange Traded Fund (ETF) that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors that are relevant to the Fund’s investment theme of the genomics revolution.
